PolyPid (PYPD)
Develops local prolonged-release therapies led by D-PLEX100 for surgical-site infection prevention.
$5.28
At close−0.05 (−0.94%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions20 holders · as of Mar 31, 2026 | 16.34% | 3.12M ADS | |
| Insiders8 holders · as of Mar 26, 2026 | 16.13% | 3.08M ADS | |
| Strategic holders1 holder · as of May 4, 2026 | 26.21% | 5.00M ADS | |
| Otherremainder | 41.32% | 7.88M ADS |
19.08M ADS (1 ADS = 3 ordinary shares) as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Dec 2024 annual report; nothing newer is on file here.
Institutions13F, as of Mar 31, 2026
20 holders · 3.12M shares · 3 new positions · 6 increased · 6 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Aigh Capital Management LLC | 1.59M | 8.35% | +250.6K | Apr 30, 2026 |
| Rosalind Advisors, Inc. | 597.9K | 3.13% | −98.6K | May 14, 2026 |
| Dafna Capital Management LLC | 207.9K | 1.09% | 0 | May 15, 2026 |
| Morgan Stanley | 176.9K | 0.93% | −31.4K | May 15, 2026 |
| J. Goldman & Co LP | 149.5K | 0.78% | −22.8K | May 15, 2026 |
| Adar1 Capital Management, LLC | 104.0K | 0.54% | 0 | May 18, 2026 |
| Symmetry Peak Management LLC | 87.2K | 0.46% | −40.1K | May 15, 2026 |
| Citadel Advisors LLC | 57.8K | 0.30% | +47.0K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Aurum Ventures M.K.I. Ltd. | 24.40% | 5.00M | 13G | May 4, 2026 ↗ |
| Rodney Hodges | 19.90% | 2.24M | 13G | Feb 14, 2025 ↗ |
| Yehuda Nir | 10.10% | 1.07M | 13G | May 15, 2025 ↗ |
| Rosalind Advisors, Inc. | 9.90% | 5.38M | 13G | May 12, 2026 ↗ |
| Orin Hirschman | 9.80% | 1.79M | 13G | Jan 30, 2026 ↗ |
| Aharon Lukach | 5.20% | 538.6K | 13G | May 28, 2025 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.